Skip to Main Content

Paper Details

Lirentelimab for severe and chronic forms of allergic conjunctivitis.
J Allergy Clin Immunol
14
2022
Author NameAffiliation
Quan Dong NguyenByers Eye Institute, Stanford University
Vishal JhanjiUniversity of Pittsburgh
Charles Stephen FosterMassachusetts Eye Research & Surgery Institution
  • 1 - 3

Datasets

Release 1.2